ZIM
TECH icon

Zacks Investment Management’s Bio-Techne TECH Stock Holding History

Zacks Investment Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-10,088
Closed -$1.14M – 650
2021
Q2 		$1.14M Buy
+10,088
New +$1.06M 0.02% 349
2019
Q3 		– Sell
-29,252
Closed -$1.52M – 579
2019
Q2 		$1.52M Buy
+29,252
New +$1.47M 0.03% 323

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
OCBV
Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
DDC
DF Dent & Co Baltimore, Maryland $5.27B AUM 7.89% 1-Year Est. Return

Zacks Investment Management's TECH Position: Q3 2021 in Review

Zacks Investment Management sold out of Bio-Techne (TECH) in Q3 2021, closing a stake of 10,088 shares — an estimated $1.14M sold.

Zacks Investment Management first reported a position in TECH in Q2 2019 and held it in 2 quarters. The position peaked at $1.52M in Q2 2019. 566 funds tracked by Wall St. Rank hold TECH as of Q3 2021.

  • Zacks Investment Management reported no remaining Bio-Techne position as of Q3 2021 after selling out during the quarter.
  • Zacks Investment Management sold 10,088 Bio-Techne shares in Q3 2021, an estimated $1.14M.
  • Zacks Investment Management first reported a position in Bio-Techne in Q2 2019 and held it in 2 quarters.
  • Zacks Investment Management's Bio-Techne position peaked at $1.52M in Q2 2019.
  • 566 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2021.

Based on Zacks Investment Management's 13F filing for Q3 2021, filed 15 Nov 2021.